Specialty & Complex Injectable Manufacturing Vendors
Vendors providing specialty & Complex Injectable Manufacturing as a distinct development or manufacturing capability.
Related workflows
CDMO / CMO · +1 more type
Symbiosis Pharmaceutical Services is a CDMO providing aseptic fill-finish, sterile injectable manufacturing and clinical packaging.
Evidence-backed capability match
“Symbiosis is licensed to aseptically manufacture small volume liquids, biological medicinal products, suspensions and lyophilisates for commercial use.”Source: symbiosis-pharma.com
Also offers: Sterile Injectable Manufacturing, Aseptic Fill-Finish, +2 more
CRO / Research Services Provider · +5 more types
Frontage Laboratories is a CRO and CDMO providing bioanalysis, DMPK and ADME studies, toxicology, Phase I support, and drug manufacturing.
Evidence-backed capability match
“Sterile Injectables – Solutions, Long Acting Injectables (LAI), Nano Particles (SLN), and Nano Emulsions”Source: frontagelab.com
Also offers: Bioanalysis & Biomarker Assay Services, Integrated CDMO/CMO Services, +3 more
Compare listed vendors
What this covers: Development and sterile manufacturing of complex injectable drug products such as suspensions, emulsions, long-acting formulations, or other specialized parenterals.
| Vendor | Delivery model | Also offers | In their words |
|---|---|---|---|
| Frontage Laboratories | CRO / Research Services Provider | Drug Product Manufacturing, Oral Solid Dose Manufacturing, Sterile Injectable Manufacturing, Aseptic Fill-Finish | “Sterile Injectables – Solutions, Long Acting Injectables (LAI), Nano Particles (SLN), and Nano Emulsions”frontagelab.com · reviewed Oct 14, 2026 |
| Symbiosis Pharmaceutical Services | CDMO / CMO | Drug Product Manufacturing, Sterile Injectable Manufacturing, Aseptic Fill-Finish, Lyophilization (Freeze-Drying) Services | “Symbiosis is licensed to aseptically manufacture small volume liquids, biological medicinal products, suspensions and lyophilisates for commercial use.”symbiosis-pharma.com · reviewed Oct 28, 2026 |